Webinars and videos
Myeloma Patients Europe (MPE) has organised a number of webinars and videos focused on access, Health Technology Assessment (HTA) and other regulatory topics:
Webinars
- MPE and ALAN webinar | Patient and clinician involvement in the EU HTA regulation. The webinar was organised by Myeloma Patients Europe (MPE) and Acute Leukemia Advocates Network (ALAN) and counted with the participation of the following speakers:
- Anke-Peggy Holtorf, moderator, Steering Committee member and project coordinator for the Patient and Citizen Involvement in HTA Interest Group, Health Technology Assessment international (HTAi)
- François Houÿez, Treatment Information and Access Director / Health Policy Advisor, European Organisation for Rare Diseases (EURORDIS)
- Mihai Rotaru, Director Market Access, European Federation of Pharmaceutical Industries and Associations (EFPIA)
- Mirjana Huic, HTA independent specialist in HTA/EBM Centre, Croatia
- Robin Doeswijk, Head of European Affairs, European Hematology Association (EHA)
MPE/ALAN Webinar | EU HTA. The webinar was given by Béla Dajka, policy officer at the Directorate-General for Health and Food Safety in the European Commission. He is part of the team working on the implementation of the EU HTA regulation.
MPE and ASCERTAIN Webinar | Basics of medicines pricing in Europe. The webinar was given by Sabine Vogler, Director of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies and Head of Pharmacoeconomics Department, Austrian National Public Health Institute. The webinar was held as part of Horizon Europe ASCERTAIN, an EU funded project working to promote access to medicines through the development of open access policy tools including pricing and value assessment models.
Videos
- EHA 2024 | Unmet medical need in the EU pharmaceutical legislation. Maria Cavaller Bellaubi, Patient Engagement and Development Director, EURORDIS, explains unmet medical needs in the EU pharmaceutical legislation presented at the 2024 European Hematology Association annual congress in Madrid, Spain.
EHA 2024 | Fair pricing: Does the value of new medicines in haematology justify the high prices? Professor Doctor Uyl-de Groot explains fair pricing in haematology presented at the 2024 European Hematology Association annual congress in Madrid, Spain.
MPE Masterclass 2024 | EU Health Technology Assessment Regulation. Interview filmed with Valentina Strammiello, Director of Programmes, EPF project portfolio and represents EPF in HTA-related activities in the European Health Parliament initiative, to summarise the session "EU Health Technology Assessment Regulation", held at the MPE Masterclass in May 2024.
MPE Masterclass 2024 | Cross border medicine and trials access. Claudia Louati, Head of Policy at European Patients' Forum (EPF) summarises the session "Cross-border access to medicine and trials", held at the MPE Masterclass in May 2024.